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Abstract
Decreased heart rate variability (HRV) is associated with
a worse prognosis in a variety of diseases and disorders.
We evaluated the determinants of short-period HRV in a
random sample of 149 middle-aged men and 137 wom-
en from the general population. Spectral analysis was
used to compute low-frequency (LF), high-frequency
(HF) and total-frequency power. HRV showed a strong
inverse association with age and heart rate in both sexes
with a more pronounced effect of heart rate on HRV in
women. Age and heart rate-adjusted LF was significantly
higher in men and HF higher in women. Significant nega-
tive correlations of BMI, triglycerides, insulin and posi-
tive correlations of HDL cholesterol with LF and total
power occurred only in men. In multivariate analyses,
heart rate and age persisted as prominent independent
predictors of HRV. In addition, BMI was strongly nega-
tively associated with LF in men but not in women. We
conclude that the more pronounced vagal influence in
cardiac regulation in middle-aged women and the gen-
der-different influence of heart rate and metabolic fac-
tors on HRV may help to explain the lower susceptibility
of women for cardiac arrhythmias.
Copyright © 2001 S. Karger AG, Basel
Introduction
Heart rate variability (HRV) has been recognized as a
noninvasive tool for the assessment of cardiovascular
autonomic balance. Recent investigations have shown
that decreased HRV is associated with a worse prognosis
in a variety of diseases and disorders [1, 2]. Results from
population-based follow-up studies revealed that lower
HRV is associated with the risk of coronary heart disease
and death [3, 4].
HRV can be assessed by time-domain analysis or by
frequency-domain analysis. The latter enables us to calcu-
late different components of the power spectrum by spec-
tral density analysis. Thus, the high-frequency (HF) com-
ponent, which measures the amplitude of sinus node
respiratory arrhythmias, mainly depends upon the effects
of vagal modulation on sinus node, whereas low-frequen-
cy power (LF) comprises both sympathetic and vagal
oscillations; however, some authors suggest that LF repre-
sents predominantly sympathetic modulation [5]. Most
research to date has been performed in cardiac patients or
in high-risk individuals with diabetes or neurological dis-
orders. There are only few studies that investigated the
determinants and correlates of HRV as it occurs in the
general population [6–8]. We present here results from a
study that was carried out in middle-aged men and wom-
en from a representative population sample in southern
Germany.
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Subjects and Methods
Study Population
The subjects of this analysis were participants of the German
sample of a trinational population-based study [9]. Age-stratified
random samples of men and women aged 45–65 years were drawn
from the population of Augsburg (Germany). One hundred and fifty-
three men and 143 women were examined after an overnight fast
(participation rate 71%).
Interview and Physical Examination
Interview questionnaires were employed to assess smoking hab-
its, alcohol consumption, use of medications and the medical history.
Body weight was measured in light clothing with precision to the
nearest 0.1 kg. Body height was measured without shoes to the near-
est 0.5 cm. Body mass index (BMI) was calculated as weight (in kg)
divided by height (in m) squared. Obesity was defined according to
National Institutes of Health Consensus Development Panel criteria
as a BMI greater than 27.3 kg/m2 in men and 27.8 kg/m2 in women
[10]. Blood pressure was measured 3 times on the right arm of sitting
subjects by an oscillometric automated sphygmomanometer (BOSO
Oscillomat) after a resting period of at least 5 min. The average of the
second and third measurement was used for this analysis. Hyperten-
sion was defined as systolic blood pressure 1140 mm Hg or diastolic
blood pressure 190 mm Hg or use of antihypertensive medication.
Fasting blood samples were drawn at the end of the physical
examination. Serum and EDTA and citrated plasma samples were
subsequently stored in liquid nitrogen (–196°C) in Augsburg. The
frozen samples were later transported on dry ice to the Institute of
Arteriosclerosis Research Laboratory at the University of Münster,
Germany. Concentrations of total cholesterol, HDL cholesterol, tri-
glycerides and glucose were quantified using a Hitachi 917 autoana-
lyzer. Determinations of cholesterol, triglycerides and HDL choles-
terol were controlled by the NHLBI Lipid Standardization Program
organized by the Centers of Disease Control (CDC; Atlanta, Ga.,
USA). Insulin was measured by the use of a commercially available
radioimmunoassay. Diabetes was defined as use of insulin or oral
antidiabetic drugs or a fasting glucose 1126 mg/dl [11].
Analysis of HRV
Holter recording was carried out using a Marquette 8500 record-
er. The recordings were undertaken in a quiet room under standard-
ized conditions after a resting period of at least 10 min. After connec-
tion of chest leads in the supine position the recordings were per-
formed during 6 min of silent supine free breathing, and then 6 min
of supine metronomic controlled breathing at 15 breaths per minute.
Holter cassette tapes were analyzed on a Marquette series 8000 anal-
ysis system using two channels: a modified V5 lead and a modified
V1 lead. Files with RR intervals and their annotations (normal beats,
ectopic beats and artifacts) were transferred to a 486 personal com-
puter through an RS-232 serial port using the XMODEM protocol.
RR intervals were calculated utilizing a computer program and edit-
ing routines developed by Sapoznikov et al. [12]. Subjects with atrial
fibrillation, excessive ectopic beats or technically inadequate record-
ings were excluded (n = 4 men and n = 6 women). Five-minute
epochs of heart rate as a function of time were used for power spec-
trum (power) analysis. Power analysis was performed with a 16th
order autoregressive model and by solving the Yule-Walker equa-
tions with the Levinson algorithm [13]. Three frequency bands were
computed: 0.0033 to !0.04 Hz (very low), 0.04 to !0.15 Hz (low),
and 0.15 to 0.40 Hz (high). Although the very low frequency band is
computed and it has been shown to be reliably measured in 5-min
recordings [8], its use in short-term recordings (!5 min) generally has
not been recommended [5]. In the present paper we, therefore, report
the area of the LF band in milliseconds squared, the area of the HF
band in milliseconds squared and the total power between 0.0033
and 0.40 Hz (total power) in milliseconds squared. To express the
relative contribution of the respective frequency bands to total pow-
er, normalized units were calculated as the ratio between the power
of each component and the total power less the very low component
multiplied by 100 [14, 15]. Two time domain measures, the standard
deviation (SD) of RR intervals and the root mean square of succes-
sive differences in RR intervals (RMSSD), were also calculated.
Because of their high correlation with the spectral parameters (r =
0.99 for SD with total power and r = 0.95 of RMSSD with HF) they
did not provide additional information and, therefore, are not con-
sidered in the present paper. Finally, to standardize respiratory rate
because differences in breathing frequency could influence differ-
ences in heart rate dynamics, metronomic controlled breathing was
performed [8].
Statistical Analysis
Results are given as mean values. All variables were normally dis-
tributed except measures of HRV as well as concentrations of insulin
and triglycerides. Accordingly, not normally distributed variables
were naturally log-transformed. Univariate relations were assessed
by Pearson’s product-moment correlation. Groups were compared
with Student’s two-tailed unpaired t test for continuous variables and
by ¯2 tests for prevalences. On the basis of the assumption of detect-
ing a difference of at least 0.3 ms2 in log-transformed HRV parame-
ters between men and women at a 80% power, it was estimated that a
sample size of more than 200 is sufficient. At the same power, for
subgroup comparisons, e.g. diabetics versus nondiabetics in men and
women, respectively, the sample sizes of men and women were suffi-
cient enough for detecting a difference of 0.4 ms2 (about 10% of the
respective means). Linear regression modeling was used for multivar-
iate analysis. In order to assess gender differences and to account for
the potential confounding effect of other HRV determinants, we
tested the gender difference by use of an interaction term in a linear
regression model encompassing the data of men and women while
controlling for all factors univariately associated with one of the
HRV indices. Forward stepwise multiple regression analysis was
used to select variables independently related to the HRV parame-
ters. To avoid failing to take account of potential HRV determinants
due to low numbers, a significance level of 0.1 was applied for the
univariate analyses of table 2; otherwise p values ! 0.05 were consid-
ered as statistically significant. All analyses were carried out with the
SAS® System for Windows Release 6.11.
Results
Table 1 shows the characteristics of our study popula-
tion. Men had a less favorable cardiovascular risk profile
than women with higher levels of blood pressure, glucose,
insulin, triglycerides and higher mean HDL cholesterol.
Men also smoked more often.
Age, years
Heart rate
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Table 1. Characteristics of the study
population Men
(n = 149)
Women
(n = 137)
p value for
difference
56.0B5.9 55.9B5.6 0.9
Height, cm 172.7B6.6 161.1B6.3 0.0001
BMI, kg/m2 27.9B4.0 27.4B4.9 0.28
Systolic BP, mm Hg 131.1B17.0 127.1B16.8 0.06
Diastolic BP, mm Hg 82.0B9.2 76.8B9.1 0.0001
Heart rate, beats/min 68.8B10.1 70.9B10.1 0.09
Total cholesterol, mg/dl 238B47 235B42 0.5
HDL-cholesterol, mg/dl 48.5B14.0 59.8B14.5 0.0001
Glucose, mg/dl 111B24 104B26 !0.02
Insulin, IU 119.1B61.9a 100.9B60.2a !0.01
Triglycerides, mg/dl 120.3B70.4a 87.9B66.5a 0.0001
Hypertension, % 43 (64) 33 (45) 0.10
Obesity, % 51 (76) 45 (62) 0.33
Smoking, % 24 (36) 10 (13) 0.002
Diabetes, % 10 (15) 4 (6) 0.11
Values in the upper part represent mean B SD. Values in parentheses represent number.
a Geometric mean with approximation of standard deviation.
Table 2. Pearson correlation coefficients between HRV parameters and the other variables
Men (n = 149)
LF power HF power total power
Women (n = 137)
LF power HF power total power
–0.29* –0.35** –0.37** –0.42** –0.64** –0.50**
BMI –0.26** –0.17* –0.28** 0.01 –0.07 –0.01
Systolic BP –0.07 –0.03 –0.09 –0.08 –0.08 –0.08
Diastolic BP –0.04 –0.01 –0.06 –0.10 –0.16* –0.15o
Age –0.16** –0.18* –0.19* –0.16o –0.15o –0.15o
Height 0.16* 0.19* 0.15* 0.04 0.12 0.08
Total cholesterol 0.04 0.08 0.02 –0.09 –0.09 –0.10
HDL cholesterol 0.17* 0.15* 0.16* –0.04 0.01 –0.01
Triglycerides –0.17* –0.05 –0.17* 0.12 0.00 0.01
Glucose –0.12 –0.12 –0.13o 0.08 0.06 0.06
Insulin –0.20* –0.04 –0.21* 0.01 –0.02 0.00
o p ! 0.1; * p ! 0.05; ** p ! 0.001.
LF power = Area at low frequency (0.04 to !0.15 Hz); HF power = area at high frequency (0.15 to !0.40); total
power = total power spectrum (0.0033 to !0.40 Hz). The values for the HRV parameters, insulin and triglycerides
were naturally log-transformed.
Short-Term HRV Measured under Free Breathing
Conditions
Correlation coefficients between HRV indices ob-
tained with free breathing and cardiovascular risk factors
and anthropometric variables were assessed in men and
women (table 2). Heart rate was inversely associated with
LF, HF and total power (p ! 0.001) and these correlations
were particularly pronounced in women (correlation coef-
ficients from 0.42 to 0.60). The inverse associations with
age were less marked (p ! 0.05 in men, p ! 0.1 in women).
LF power, ms2
Obese
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Table 3. Crude and adjusted mean values (B SD) of LF, HF and total power in men and women
Crude
men (n = 149) women (n = 137) p value
Adjusted for age and heart rate
men (n = 149) women (n = 137) p value
5.04B0.94 4.72B1.07 !0.01 5.00B0.92 4.76B0.92 !0.03
LF as NU, % 67.6B14.7 58.5B16.6 !0.0001 67.9B14.7 58.1B16.5 !0.0001
HF power, ms2 4.22B1.05 4.33B1.08 0.38 4.17B0.90 4.39B0.90 !0.05
HF as NU, % 32.4B14.7 41.5B19.6 !0.0001 32.1B14.6 41.8B19.6 !0.0001
Total power, ms2 6.19B0.83 6.03B0.89 0.1 6.16B0.75 6.07B0.76 0.31
LF power = Area at low frequency (0.04 to !0.15 Hz); HF power = area at high frequency (0.15 to ! 0.40); total power = total power
spectrum (0.0033 to !0.40 Hz); the values for the areas and total power are naturally log-transformed and expressed in ln ms2;
NU = normalized units, calculated as the ratio between the power of each component and the total power less the very low component multi-
plied by 100.
Table 4. Age- and heart rate-adjusted mean values (B SD) of LF, HF and total power in relation to obesity and
smoking
Men (n = 149)
no yes p value
Women (n = 137)
no yes p value
n = 75 n = 74 n = 73 n = 64
LF power, ms2 5.24B0.93 4.80B0.90 !0.01 4.76B1.21 4.67B0.87 0.56
HF power, ms2 4.37B0.98 4.18B1.08 !0.07 4.42B1.15 4.23B0.99 0.21
Total power, ms2 6.36B0.79 6.02B0.82 !0.01 6.10B0.99 6.05B0.76 0.26
Smoking n = 113 n = 36 n = 124 n = 13
LF power, ms2 5.10B0.97 4.86B0.98 0.19 4.73B1.09 4.65B0.76 0.77
HF power, ms2 4.24B0.98 4.19B1.23 0.82 4.39B1.07 3.81B0.90 !0.02
Total power, ms2 6.23B0.80 6.09B0.92 0.38 6.05B0.91 5.87B0.58 0.45
LF power = Area at low frequency (0.04 to !0.15 Hz); HF power = area at high frequency (0.15 to !0.40); total
power = total power spectrum (0.0033 to !0.40 Hz); the values for the areas and total power are naturally log-
transformed and expressed in ln ms2.
In men, the BMI was significantly related to a decreased
HF, LF and total power (p ! 0.01). Furthermore, triglycer-
ides and insulin as well as low HDL cholesterol levels
were all inversely related to LF and total power in men
(p ! 0.05). In women, only diastolic blood pressure could
be identified as a very modest correlate of HRV.
Though having similar total power, men and women
differed markedly in the components of HRV (table 3).
Mean LF was significantly higher in men (p ! 0.01). This
difference persisted after adjustment for age and heart
rate, whereas unadjusted HF power was not significantly
different between men and women; however, adjusting
for age and heart rate revealed higher mean HF in women
(p ! 0.05). Expression in relative terms revealed that the
proportionate contributions of HF and LF to total power
were highly different in men and women (p ! 0.001).
We further assessed HRV in subjects by a risk factor
group. Obesity was a pronounced correlate of generally
reduced HRV in men only (table 4). Women smoking
more than 10 cigarettes a day showed an impaired HF
power (p ! 0.02). While diabetes was associated with low-
er crude HF power in men and women (4.29 B 1.01 vs.
3.82 B 1.17 ms2 in diabetic vs. nondiabetic men, respec-
tively, p = 0.05; 4.39 B 1.03 vs. 3.64 B 1.54 ms2 for wom-
en, respectively, p ! 0.04) control for age and heart rate
rendered these differences insignificant (4.25 B 1.00 vs.
LF power, ms2
LF power, ms2
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Table 5. Regression coefficients (ß) and partial R2 values of factors related to LF and HF power in the final model
after a forward stepwise procedure
Men (n = 149)
ß partial R2 p value
Women (n = 137)
ß partial R2 p value
Heart rate –0.025 0.08 0.0003 –0.045 0.19 0.0001
BMI –0.05 0.053 0.003 – – –
Age –0.026 0.026 0.036 –0.032 0.023 0.048
HF power, ms2
Heart rate –0.03 0.125 0.0001 –0.07 0.42 0.0001
Age –0.03 0.038 0.01 –0.029 0.02 0.017
HDL 0.01 0.019 0.07 – – –
LF power = Area at low frequency (0.04 to !0.15 Hz); HF power = area at high frequency (0.15 to !0.40); the
values for the areas are naturally log-transformed and expressed in ln ms2.
Table 6. Regression coefficients (ß) and partial R2 values of factors related to LF and HF power in the same model as
in table 5 with HRV parameters measured under metronomic breathing conditions
Men (n = 146a)
ß partial R2 p value
Women (n = 137)
ß partial R2 p value
Heart rate –0.015 0.023 0.05 –0.04 0.16 0.0001
BMI –0.072 0.11 0.0001 – – –
Age –0.027 0.027 0.036 – – –
HF power, ms2
Heart rate –0.038 0.086 0.0001 –0.075 0.36 0.0001
BMI –0.10 0.128 0.0001 –0.027 0.014 0.075
Insulin –0.0018 0.031 0.017 – – –
HDL – – – 0.017 0.033 0.008
LF power = Area at low frequency (0.04 to !0.15 Hz); HF power = area at high frequency (0.15 to !0.40); the
values for the areas are naturally log-transformed and expressed in ln ms2.
a Number is reduced to 146 because 3 men were not able to follow metronomic breathing.
4.10 B 1.19 ms2 in diabetic vs. nondiabetic men, respec-
tively, p = 0.5; 4.37 B 1.02 vs. 3.93 B 1.61 ms2  for wom-
en, respectively, p = 0.11; data not shown). Similarly,
HRV was not markedly different in men or women with
and without hypertension (data not shown). Finally, HRV
of women older than 50 years on hormonal replacement
therapy (HRT; n = 95) did not differ significantly from
that in women not taking HRT (n = 22): 4.71 B 1.16 vs.
4.39 B 0.84 ms2 (p = 0.23) for LF; 4.30 B 1.09 vs. 3.91 B
0.84 ms2 (p = 0.12) for HF, and 6.00 B 0.96 vs. 5.76 B
0.63 ms2 (p = 0.26) for total frequency, respectively (data
not shown).
In the final model of the multivariate analysis, heart
rate, age and – for men only – BMI remained as predictors
of LF power and heart rate, age and – of borderline signif-
icance in men only – HDL cholesterol for HF power.
Heart rate alone accounted for 19% of the variance of LF
power and 42% of the variance of HF power in women.
Its impact was much less prominent in men (table 5).
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The modification of the effects of heart rate or BMI on
HRV by sex was assessed specifically by modeling statisti-
cal interaction terms. We found that the association of
heart rate with decreased LF and HF power in women was
significantly stronger than that in men (R2 = 0.21, p ! 0.05
for the interaction term of LF and R2 = 0.32, p ! 0.01 for
HF, respectively). Conversely, the association of BMI
with LF in men was significantly stronger than that in
women (R2 = 0.21, p ! 0.05 for the interaction term).
Short-Term HRV under Metronomic Breathing
Conditions
Under metronomic breathing conditions results were
mostly similar to those obtained with unrestricted breath-
ing. The association between BMI and decreased HRV in
men emerged as even slightly stronger (table 6). Hyper-
tensive men revealed significantly lower HF (p ! 0.02,
adjusted for age and heart rate). Likewise, diabetic wom-
en showed decreased HF power (p ! 0.02, adjusted for age
and heart rate).
Discussion
In this study, we aimed to identify determinants of
HRV in men and women from a representative sample of
the general population. We show that middle-aged men
have higher average LF power as compared to HF compo-
nents which prevail in women: these differences became
particularly obvious when heart rate was accounted for in
the analyses or when indices were expressed in propor-
tional terms. Our findings extend previous reports of
male/female differences in HRV [7, 8, 14, 16–18] by deli-
neating that risk factors affect cardiac autonomic regula-
tion in a sex-specific way.
Heart Rate and HRV
Consistent with numerous previous reports, we found
a strong relation between heart rate and HRV indices [8,
15, 19]. We report here that the influence of heart rate on
HRV seems significantly more pronounced in women
than men. Generally, the inverse influence of heart rate
on HF was remarkably higher than that on LF power.
This finding is consistent with the observation that raised
heart rates commonly indicate sympathetic activation
[20] and might, therefore, be expected to decrease the LF
component to a lesser extent. Moreover, it has been
shown that a high resting heart rate may also result from a
decreased vagal activity [21] confirming our observation
of an inverse association of heart rate with HF power.
Anthropometry, Cardiovascular Risk Factors and
HRV
Age was inversely associated with all HRV indices and
the strength of this association was similar in men and in
women. In contrast to a previous study [19], but consis-
tent with another one [8], age contributed much less to the
variance of HRV than heart rate. This discrepancy may
be explained by the restricted age range in our study sam-
ple.
BMI plays a central role in the metabolic syndrome
(i.e. effects of metabolic factors such as lipids, glucose and
insulin) which is believed to increase the susceptibility to
severe arrhythmias and sudden death by increasing sym-
pathetic activity [22]. The influence of adiposity on auto-
nomic cardiac function has rarely been investigated. The
few studies to date have been inconsistent with findings of
reduced RR interval variation in obese men [23] while
other studies in subjects younger than 40 years found no
[7] or negative associations with HRV and BMI in both
genders [24]. In accordance with our study, previous stud-
ies observed stronger inverse associations of HRV or
heart rate with BMI in men than in women [15, 20].
In univariate analyses, the biochemical correlates of
the metabolic syndrome, HDL cholesterol, triglycerides
and insulin as well as diabetes, were associated with
decreased HRV. It has been shown that with the cluster-
ing of metabolic syndrome disorders HRV indices de-
crease [2]; however, no sex-specific analyses were re-
ported. In the present study we show that after including
BMI in the multivariate model these factors made only a
small independent contribution to the overall variance of
HRV in the general population.
Similarly, smoking which in our study as well as in
another population [7] showed an inverse association
with HF power in women, was eliminated in multivariate
analyses. It also appears that hypertension as a major car-
diovascular risk factor plays no relevant role as a determi-
nant of HRV.
Mechanisms of HRV Differences between Men and
Women
It has also been suggested previously that estrogens
have a cardioprotective effect in young women [25] as
well as in older, postmenopausal women [15]. Huikuri et
al. [14] reported a higher parasympathetic activity in post-
menopausal women given hormonal replacement thera-
py. We were unable to confirm an influence of hormone
replacement therapy in our study. However, the generally
increased parasympathetic activity in women, as reflected
by a higher average HF component, may partly explain
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the relative protection of women from cardiovascular dis-
ease [8, 26].
Study Limitations
There are limitations to the present study. HRV was
measured during the morning hours, over a short period
of 5 min, in resting conditions and in the supine position.
Thus, it may not be representative of the sympathetic/
parasympathetic balance over the 24-hour period. How-
ever, standardized application of procedures for cross-
center comparison was the predominant concern in the
original study protocol, an objective which is not achieva-
ble with 24-hour recording. Though the reliability of HRV
measurement was not assessed in the present study, a pre-
vious investigation in an Israeli sample using the same
protocol reported relatively high reliability coefficients
for short-time HRV recordings [8]. Therefore, we believe
that the associations between established risk factor levels
and resting HRV can be validly assessed with our short-
term measurements. In addition, residual confounding
and unmeasured variables may account for some of the
sex differences in HRV. For example, physical fitness
may affect HRV because physical activity is associated
with an accentuation of vagal activity [27]. On the other
hand, men in the Augsburg population tended to be physi-
cally more active than women [28] which the HRV gender
differences may even have underestimated. Finally, the
power of the study may not have been sufficient enough to
detect smaller differences (!0.4 ms2) between risk factor
groups in men and women, or in HRT use among older
women, respectively.
In conclusion, our findings add to the increasing evi-
dence that men show a higher sympathetic and women an
enhanced vagal control of heart rate. Factors related to the
metabolic syndrome determine HRV in men; however,
the overall association of HRV with cardiovascular risk
factors was rather weak. Heart rate is of outstanding
importance for both LF and HF components, more so in
women than men. Whether the gender differences in the
regulation of autonomic cardiac function are related to
the lower susceptibility of women to arrhythmias and car-
diac death requires further study.
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